BR100 Decreased By (-0.67%)
BR30 Decreased By (-0.45%)
KSE100 Decreased By (-0.59%)
KSE30 Decreased By (-0.71%)
AGHA 7.71 Decreased By ▼ -0.10 (-1.28%)
BECO 5.17 Decreased By ▼ -0.04 (-0.77%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 34.16 Increased By ▲ 0.13 (0.38%)
CNERGY 10.06 Increased By ▲ 0.10 (1%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.99 Decreased By ▼ -0.71 (-1.3%)
FFL 16.56 Decreased By ▼ -0.13 (-0.78%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 7.26 Decreased By ▼ -0.14 (-1.89%)
KOSM 5.73 Decreased By ▼ -0.04 (-0.69%)
LOTCHEM 29.20 Decreased By ▼ -0.12 (-0.41%)
MLCF 92.35 Decreased By ▼ -2.01 (-2.13%)
NBP 202.30 Decreased By ▼ -0.75 (-0.37%)
NCPL 56.70 Decreased By ▼ -0.30 (-0.53%)
NPL 66.90 Decreased By ▼ -0.80 (-1.18%)
OGDC 314.25 Decreased By ▼ -1.59 (-0.5%)
PACE 10.59 Decreased By ▼ -0.05 (-0.47%)
PAEL 42.60 Decreased By ▼ -0.60 (-1.39%)
PIBTL 16.60 Decreased By ▼ -0.14 (-0.84%)
PPL 218.20 Decreased By ▼ -1.58 (-0.72%)
PRL 51.20 Increased By ▲ 2.01 (4.09%)
PTC 70.39 Decreased By ▼ -0.14 (-0.2%)
SSGC 27.33 Decreased By ▼ -0.92 (-3.26%)
TBL 9.79 Decreased By ▼ -0.07 (-0.71%)
TELE 8.67 Decreased By ▼ -0.12 (-1.37%)
TPL 18.30 Increased By ▲ 0.06 (0.33%)
TPLP 13.51 Increased By ▲ 0.24 (1.81%)
TREET 22.59 Decreased By ▼ -0.13 (-0.57%)
TRG 59.91 Decreased By ▼ -0.23 (-0.38%)
By

UK’s export-oriented FTSE 100 started the week on a lacklustre note, dragged down by energy and mining stocks, as China dampened hopes of a rebound in commodity demand after it reiterated its zero-COVID policy to curb outbreaks.

The blue-chip FTSE 100 fell 0.5% on Monday, while the mid-cap FTSE 250 was down 0.1% by 0808 GMT.

Energy stocks and miners were off 1.1% and 0.2%, respectively, tracking commodity prices that were hit as stringent COVID-19 curbs darkened demand outlook from China.

Mortgage lender Halifax said British house prices fell in October at the fastest monthly rate since February 2021. The construction materials sector slipped 0.4%.

Miners lift FTSE 100 on China reopening optimism

GSK Plc slid 2.0% after the British drugmaker said its blood cancer drug Blenrep failed the main goal of a late-stage study.

Shares of Joules Group plunged 34.4% after the struggling British fashion retailer said it was in advanced discussions with its investors for a cornerstone investment in an equity raise for the company.

Comments

Comments are closed for this article.